PFM Health Sciences as of June 30, 2025
Portfolio Holdings for PFM Health Sciences
PFM Health Sciences holds 56 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 17.8 | $209M | 268k | 779.53 | |
| Tenet Healthcare Corp Com New (THC) | 7.5 | $88M | 499k | 176.00 | |
| McKesson Corporation (MCK) | 4.5 | $53M | 72k | 732.78 | |
| Axsome Therapeutics (AXSM) | 4.3 | $50M | 483k | 104.39 | |
| Intuitive Surgical Com New (ISRG) | 4.1 | $48M | 89k | 543.41 | |
| Penumbra (PEN) | 3.6 | $43M | 166k | 256.63 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.3 | $38M | 222k | 172.60 | |
| Soleno Therapeutics (SLNO) | 2.9 | $34M | 407k | 83.78 | |
| CVS Caremark Corporation (CVS) | 2.8 | $33M | 479k | 68.98 | |
| Outset Med Com New (OM) | 2.7 | $32M | 1.7M | 19.21 | |
| Danaher Corporation (DHR) | 2.7 | $32M | 161k | 197.54 | |
| UnitedHealth (UNH) | 2.6 | $31M | 100k | 311.97 | |
| Edwards Lifesciences (EW) | 2.6 | $31M | 393k | 78.21 | |
| Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 2.5 | $29M | 23M | 1.25 | |
| Hca Holdings (HCA) | 2.4 | $28M | 72k | 383.10 | |
| Humana (HUM) | 2.3 | $27M | 110k | 244.48 | |
| Molina Healthcare (MOH) | 2.2 | $26M | 86k | 297.90 | |
| Alnylam Pharmaceuticals (ALNY) | 2.0 | $24M | 72k | 326.09 | |
| Bridgebio Pharma (BBIO) | 1.9 | $23M | 522k | 43.18 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 1.8 | $21M | 1.2M | 16.76 | |
| Indivior Ord (INDV) | 1.7 | $20M | 1.4M | 14.74 | |
| Natera (NTRA) | 1.5 | $17M | 101k | 168.94 | |
| AmerisourceBergen (COR) | 1.4 | $16M | 53k | 299.85 | |
| Masimo Corporation (MASI) | 1.4 | $16M | 95k | 168.22 | |
| Oscar Health Cl A (OSCR) | 1.3 | $16M | 735k | 21.44 | |
| Waters Corporation (WAT) | 1.3 | $15M | 43k | 349.04 | |
| Akero Therapeutics (AKRO) | 1.2 | $14M | 266k | 53.36 | |
| Hologic (HOLX) | 1.2 | $14M | 212k | 65.16 | |
| Irhythm Technologies (IRTC) | 1.2 | $14M | 88k | 153.96 | |
| Arcutis Biotherapeutics (ARQT) | 1.1 | $13M | 923k | 14.02 | |
| Icon SHS (ICLR) | 1.1 | $13M | 88k | 145.45 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 0.9 | $11M | 17k | 617.85 | |
| United Therapeutics Corporation (UTHR) | 0.9 | $11M | 36k | 287.35 | |
| BioMarin Pharmaceutical (BMRN) | 0.8 | $9.8M | 178k | 54.97 | |
| Merus N V (MRUS) | 0.8 | $9.7M | 184k | 52.60 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.6 | $7.6M | 80k | 94.58 | |
| Abbvie (ABBV) | 0.6 | $7.6M | 41k | 185.62 | |
| Blueprint Medicines (BPMC) | 0.5 | $6.2M | 48k | 128.18 | |
| Neogenomics Com New (NEO) | 0.5 | $5.6M | 770k | 7.31 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.4 | $5.0M | 1.8M | 2.80 | |
| Amylyx Pharmaceuticals (AMLX) | 0.4 | $4.7M | 732k | 6.41 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.4 | $4.5M | 345k | 13.14 | |
| Argenx Se Sponsored Adr (ARGX) | 0.3 | $4.0M | 7.2k | 551.22 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.3 | $3.6M | 85k | 42.05 | |
| Inhibrx Biosciences (INBX) | 0.3 | $3.5M | 244k | 14.27 | |
| Io Biotech (IOBT) | 0.2 | $2.7M | 2.0M | 1.39 | |
| Uniqure Nv SHS (QURE) | 0.2 | $2.4M | 174k | 13.94 | |
| Rezolute Com New (RZLT) | 0.2 | $1.9M | 434k | 4.46 | |
| Caribou Biosciences (CRBU) | 0.1 | $1.7M | 1.4M | 1.26 | |
| Disc Medicine (IRON) | 0.1 | $1.6M | 31k | 52.96 | |
| Neurocrine Biosciences (NBIX) | 0.1 | $1.6M | 13k | 125.69 | |
| Erasca (ERAS) | 0.1 | $1.4M | 1.1M | 1.27 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.1 | $1.2M | 57k | 20.74 | |
| Viking Therapeutics (VKTX) | 0.1 | $1000k | 38k | 26.50 | |
| Sagimet Biosciences Com Ser A (SGMT) | 0.1 | $686k | 90k | 7.62 | |
| Werewolf Therapeutics (HOWL) | 0.0 | $437k | 401k | 1.09 |
